Parasitic problems in practice: therapeutic guidelines. I.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000871:Anthelmintics / Q000627:therapeutic use*; D001196:Ascariasis / Q000188:drug therapy; D001598:Bephenium Compounds / Q000627:therapeutic use; D006373:Helminthiasis / Q000188:drug therapy*; D006725:Hookworm Infections / Q000188:drug therapy; D006801:Humans; D007815:Larva Migrans / Q000188:drug therapy; D007816:Larva Migrans, Visceral / Q000188:drug therapy; D010123:Oxyuriasis / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use; D011774:Pyrvinium Compounds / Q000627:therapeutic use; D013322:Strongyloidiasis / Q000188:drug therapy; D013827:Thiabendazole / Q000627:therapeutic use; D014235:Trichinellosis / Q000188:drug therapy; D014257:Trichuriasis / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000871:Anthelmintics; D001598:Bephenium Compounds; D010879:Piperazines; D011774:Pyrvinium Compounds; D013827:Thiabendazole